0W4N.L
Formycon AG develops and markets biosimilar products. Its product pipeline includes FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious eye diseases; FYB202, a biosimilar candidate for Stelara, a biopharmaceutical used in the treatment of inflammatory diseases, such as moderate to severe psoriasis, as well as for the treatment of Crohn's disease and ulcerative colitis, which is in the Phase III clinical trial; and FYB203, a biosimilar candidate for Eylea to treat neovascular age-related macular degeneration and other eye diseases that is in Phase III clinical trials. The company is also develo...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2018-01-29
Stock Exchange
LSE
Ticker
0W4N.L
According to Formycon AG’s latest financial reports and current stock price. The company's current PE Ratio is -20.69. This represents a change of 240.76% compared to the average of -6.07 of the last 4 quarters.
The mean historical PE Ratio of Formycon AG over the last ten years is -7.58. The current -20.69 PE Ratio has changed 27.19% with respect to the historical average. Over the past ten years (40 quarters), 0W4N.L's PE Ratio was at its highest in in the June 2023 quarter at 136.42. The PE Ratio was at its lowest in in the January 2009 quarter at -215.52.
Average
-7.58
Median
-28.21
Minimum
-193.34
Maximum
373.55
Discovering the peaks and valleys of Formycon AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 261.63%
Maximum Annual PE Ratio = 373.55
Minimum Annual Increase = -499.98%
Minimum Annual PE Ratio = -193.34
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -7.39 | -162.41% |
| 2023 | 11.84 | -64.07% |
| 2022 | 32.96 | -167.24% |
| 2021 | -49.02 | -43.42% |
| 2020 | -86.64 | -37.71% |
| 2019 | -139.10 | -499.98% |
| 2018 | 34.78 | -117.99% |
| 2017 | -193.34 | 261.63% |
| 2016 | -53.46 | -114.31% |
| 2015 | 373.55 | 251.78% |
The current PE Ratio of Formycon AG (0W4N.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.47
5-year avg
-19.65
10-year avg
-7.58
Formycon AG’s PE Ratio is greater than Oryzon Genomics S.A. (-51.25), less than Inventiva S.A. (-1.21), less than Boiron S.A. (27.57), less than Medios AG (19.62), less than Transgene S.A. (-3.30), less than Stratec SE (19.30), less than Valneva SE (-9.25), less than LNA Santé S.A. (11.56), less than AB Science S.A. (-8.19), less than Vivoryon Therapeutics N.V. (-3.37),
| Company | PE Ratio | Market cap |
|---|---|---|
| -51.25 | N/A | |
| -1.21 | N/A | |
| 27.57 | N/A | |
| 19.62 | N/A | |
| -3.30 | N/A | |
| 19.30 | N/A | |
| -9.25 | N/A | |
| 11.56 | N/A | |
| -8.19 | N/A | |
| -3.37 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Formycon AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Formycon AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Formycon AG's PE Ratio?
How is the PE Ratio calculated for Formycon AG (0W4N.L)?
What is the highest PE Ratio for Formycon AG (0W4N.L)?
What is the 3-year average PE Ratio for Formycon AG (0W4N.L)?
What is the 5-year average PE Ratio for Formycon AG (0W4N.L)?
How does the current PE Ratio for Formycon AG (0W4N.L) compare to its historical average?